Cargando…
8.5 Predictors of long-term outcome of Juvenile Dermatomyositis (JDM): a Multicenter, Multinational Study of 490 patients
Autores principales: | Ferrari, C, Trail, L, Pilkington, C, Maillard, S, Cuttica, R, Katsicas, MM, Russo, R, Bandeira, M, Ferriani, V, Oliveira, S, Saad-Magalhaes, C, Silva, CA, Baca, V, Burgos-Vargas, R, Solis-Vallejo, E, Alessio, M, Alpigiani, MG, Corona, F, Falcini, F, Gerloni, V, Lepore, L, Magni-Manzoni, S, Zulian, F, Ruperto, N, Pistorio, A, Felici, E, Rossi, F, Sala, E, Martini, A, Ravelli, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334175/ http://dx.doi.org/10.1186/1546-0096-6-S1-S19 |
Ejemplares similares
-
Differences in therapeutic approach to juvenile dermatomyositis between Europe and Latin America
por: Trail, L, et al.
Publicado: (2008) -
Juvenile dermatomyositis (JDM) sine myositis
por: Schuetz, C, et al.
Publicado: (2011) -
Proposal for the development of an international minimal data collection for juvenile dermatomyositis (JDM)
por: McCann, Liza J, et al.
Publicado: (2011) -
PReS-FINAL-2184: A randomized trial in new onset juvenile dermatomyositis: prednisone versus prednisone plus cyclosporine versus prednisone plus methotrexate
por: Ruperto, N, et al.
Publicado: (2013) -
JDM update September 2014
por: Pilkington, Clarissa
Publicado: (2014)